GT Biopharma Presented Preclinical Data Demonstrating Novel Mesothelin-Targeted TriKE® Driving Cytotoxicity Across All Stages of Non-Small Cell Lung Cancer at ESMO TAT 2022

/PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...

Related Keywords

Brisbane ,Queensland ,Australia ,Jeff Miller ,Corey Davis ,David Castaneda ,Gregory Berk ,Exchange Commission ,Prnewswire Gt Biopharma Inc ,Source Gt Biopharma Inc ,Anticancer Therapies Congress ,University Of Minnesota ,Gt Biopharma Inc ,Nasdaq ,Chief Medical Officer ,Tri Specific Killer Engager ,Astrolabe Diagnostics ,Consulting Chief Scientific Officer ,Board Number ,Gt Biopharma ,Nc ,